El Futuro en el Tratamiento del Cáncer Renal - page 18

PT2385: First-In-Class HIF-2α Antagonist for the Treatment of RCC

Simon MC. N Engl J Med 2016

Key J. J Am Chem Soc. 2009

AACR New Drugs on the Horizon, April 19, 2015. Eli Wallace, Ph.D

Presented By Kevin Courtney at 2016 ASCO Annual Meeting

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27,28,...36